Literature DB >> 12641627

A 3-year prospective study to assess uterine growth in girls with Turner's syndrome by pelvic ultrasound.

Ciara M McDonnell1, Lee Coleman, Margaret R Zacharin.   

Abstract

OBJECTIVE: Adult women with Turner's syndrome who have used the donor ovum IVF programme are reported to have reduced pregnancy outcome with an increased risk for first trimester spontaneous abortion. This is considered to be related to a small uterine size and reduced endometrial thickness. This study examines whether adequate oestrogen replacement during the early adolescent years will result in normal adult uterine dimensions, with consequent reduction in these pregnancy risks.
DESIGN: A prospective evaluation of uterine dimensions by pelvic ultrasound examination over 3 years, in a group of 18 girls commencing pubertal induction with oestrogen or entering puberty spontaneously. PATIENTS: Girls with Turner's syndrome attending the outpatient clinc at the Royal Children's Hospital and due to start oestrogen treatment were invited to participate in the study. MEASUREMENTS: Data were collected for clinical parameters of age, pubertal staging, menarche, oestrogen dose and karyotype. Ultrasonographic measurements of uterine length, sagittal and transverse width, endometrial cavity and identification of ovaries were also included.
RESULTS: The mean age at commencement of the study was 14.6 years, mean age at final evaluation was 17.1 years. Karyotype was 45XO in 6/18, mosaic in 12/18. Spontaneous pubertal onset occurred in 5/18. One of these later required the addition of oestrogen treatment. Pubertal induction with oestrogen was used in 13/18 girls. A total of 15/18 girls have either achieved spontaneous menarche or are using adult doses of oestrogen and progestogen with regular withdrawal bleeds. All 18 girls have achieved a uterine length of 5.8-8.6 cm (mean 7.04 cm) within the normal adult range (5-8 cm). Mean uterine volume was 30.23 cm3.
CONCLUSION: The study suggests that adequate oestrogen replacement in early to mid adolescence mimicking spontaneous timing of puberty results in normal uterine growth and adult uterine dimensions. Further follow-up of uterine growth in these girls is warranted.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12641627     DOI: 10.1046/j.1365-2265.2003.01737.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

Review 1.  New issues in the diagnosis and management of Turner syndrome.

Authors:  Carolyn A Bondy
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

Review 2.  Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency.

Authors:  Laurentiu Craciunas; Nikolaos Zdoukopoulos; Suganthi Vinayagam; Lamiya Mohiyiddeen
Journal:  Cochrane Database Syst Rev       Date:  2022-10-06

3.  Uterine development in Turner syndrome.

Authors:  Vladimir K Bakalov; Thomas Shawker; Irene Ceniceros; Carolyn A Bondy
Journal:  J Pediatr       Date:  2007-09-17       Impact factor: 4.406

4.  Menarche in primary ovarian insufficiency after a month of hormone replacement therapy: a case report.

Authors:  Biwen Cheng
Journal:  J Med Case Rep       Date:  2021-02-22

5.  Late-Onset Puberty Induction by Transdermal Estrogen in Turner Syndrome Girls-A Longitudinal Study.

Authors:  Aneta Monika Gawlik; Magdalena Hankus; Kamila Szeliga; Aleksandra Antosz; Tomasz Gawlik; Kamil Soltysik; Agnieszka Drosdzol-Cop; Krzysztof Wilk; Grzegorz Kudela; Tomasz Koszutski; Ewa Malecka-Tendera
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-08       Impact factor: 5.555

6.  ESR1 polymorphism (rs2234693) influences femoral bone mass in patients with Turner syndrome.

Authors:  Renata C Scalco; Ericka B Trarbach; Edoarda V A Albuquerque; Thais K Homma; Thais H Inoue-Lima; Mirian Y Nishi; Berenice B Mendonca; Alexander A L Jorge
Journal:  Endocr Connect       Date:  2019-11       Impact factor: 3.335

7.  Uterine Development During Induced Puberty in Girls with Turner Syndrome.

Authors:  Monika Obara-Moszynska; Lukasz Dzialach; Barbara Rabska-Pietrzak; Marek Niedziela; Karina Kapczuk
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-06       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.